Combinations of olmesartan and a calciumchannel blocker or a diuretic inelderly hypertensive patients: A randomized, controlled trial

Abbreviations: ACCOMPLISH, Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension; ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor blocker; BP, blood pressure; CCB, calcium channel blocker; COLM, Combinations of OLMesartan; SAE, serious adverse event The authors’ contributions, members of the COLM Study Committees, and the list of investigators are presented in the Appendix. 1 Some data from this report were presented as a late-breaking clinical trial at the 23rd European Meeting on Hypertension and Cardiovascular Protection (Milan, Italy), 16 June 2013.